NCT02524223

Prevalence of HPV Transmission During Medically Assisted Procreation Procedures

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 915 (actual)
• Sponsor: Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Human PapillomaVirus (HPV) are ones of the main causal agents of sexually transmitted diseases. Numerous HPV genotypes such as 16, 18, 31 or 45 are considered to be at high risk of oncogenicity especially for the anal and cervical mucosa. At the present time, no recommendations exist on the risk related to HPV during Medically Assisted Procreation (MAP) procedures. The main objective of this prospective multicentric cohort study is to evaluate the prevalence of transmission of HPV via the semen during MAP program. Secondary objectives are to evaluate (1) the prevalence of HPV DNA in the sperm fractions of men enrolled in MAP, (2) the efficacy of spermatozoal pellet preparation procedures to eliminate HPV, (3) the correlation between HPV and male infertility and (4) the correlation between HPV and success rate of procreation. Results could contribute to revise guidelines of MAP procedures and HPV vaccination policy.

Conditions

• Human Papillomavirus (HPV)
• Medically Assisted Procreation (MAP)
• Infertility

Interventions

Type	Name	Description
OTHER	Systematic HPV DNA assay in semen and cervicovaginal scrape	Screening of HPV status at the genital level of males enrolled in MAP program.
OTHER	Systematic HPV DNA cervicovaginal scrape	Screening of HPV status at the genital level of females enrolled in MAP program.
OTHER	systematic HPV Status in newborns in case of pregnancy

Timeline

• Start date: 2012-07-12
• Primary completion: 2016-02-22
• Completion: 2016-02-22
• First posted: 2015-08-14
• Last updated: 2018-09-24

Locations

5 sites across 1 country: France